about
Early adaptive humoral immune responses and virus clearance in humans recently infected with pandemic 2009 H1N1 influenza virusBoosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu.Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.Safe pseudovirus-based assay for neutralization antibodies against influenza A(H7N9) virus.MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells.Differential compartmentalization of HIV-targeting immune cells in inner and outer foreskin tissue.Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection.IFN-stimulated gene LY6E in monocytes regulates the CD14/TLR4 pathway but inadequately restrains the hyperactivation of monocytes during chronic HIV-1 infection.Deglycosylation of HIV-1 AE Gp140 enhances the capacity to elicit neutralizing antibodies against the heterologous HIV-1 clade.CTL responses to HSP47 associated with the prolonged survival of patients with glioblastomas.Potent T cell responses induced by single DNA vaccine boosted with recombinant vaccinia vaccine.Development and validation of a liquid chromatography-mass spectrometry metabonomic platform in human plasma of liver failure caused by hepatitis B virus.Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.The use of PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as a mucosal DNA delivery vector and the activation of innate immunity and improvement of HIV-1-specific immune responses.Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses.Alpha-1 antitrypsin variants in plasma from HIV-infected patients revealed by proteomic and glycoproteomic analysis.The increased sensitivity of CTLs induced by vaccinia vector is developed as intrinsic feature in vivo and independent of microenvironment in vitro.The prognostic and diagnostic use of microRNA expression in chronic HIV infectionMucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responsesSequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes
P50
Q30406631-10975535-726E-4B20-995B-3B64588237D6Q33602726-C5C2062B-21AB-4F2B-B8F1-6CDB26E00152Q33999299-990E3BEC-2DF6-4347-8867-D233ECCAD745Q37262012-8D0D9799-67FE-4DEC-990E-A37279EFCDDAQ37340864-D126AA0F-C365-4880-B59E-4CC9023E7ACDQ37484007-B8E18C83-9976-4472-AFF2-FA8C2E5483BBQ37495275-DBA9F409-F17F-4314-8EE5-B436CA0828FDQ38956177-9502B9C1-C1BB-4E60-A6E9-0EBAC2C53AB8Q39705794-F1E2CDEB-00CA-4776-9C5A-E60FEE0C2141Q42231846-D2300320-3462-4B9F-9F26-737BFC668CA3Q42267194-17DFA83A-9154-4F3D-B8B1-DAD5542355DBQ42920226-519C8F77-DFF7-465D-8DA6-5ED5C0016594Q43039177-C9BF3677-C700-4E40-A66B-344AE515B94DQ43271145-4D01C5EA-E869-4DF3-BFFB-66E36BE20B5FQ44306671-787616D7-75B9-4050-9C85-29D4912FDA64Q46366264-F53E529E-2742-4A5F-A1E1-E1DE81B6E8C2Q46984278-2F1D30F9-A086-4C7C-B4E7-C33936C85A4CQ59291000-A6AC8C12-7815-4F37-A22F-D7960AA1E15EQ64127566-D026E562-25F4-4A32-BAAB-B90163C9534DQ79372590-3CB7752C-8C89-4DD1-942A-B9415E9C1834
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chao Qiu
@ast
Chao Qiu
@en
Chao Qiu
@es
Chao Qiu
@nl
Chao Qiu
@sl
type
label
Chao Qiu
@ast
Chao Qiu
@en
Chao Qiu
@es
Chao Qiu
@nl
Chao Qiu
@sl
prefLabel
Chao Qiu
@ast
Chao Qiu
@en
Chao Qiu
@es
Chao Qiu
@nl
Chao Qiu
@sl
P1053
M-6702-2014
P106
P108
P31
P3829
P496
0000-0001-9401-5219